HER-2 K753E
|
Breast Cancer
|
HER-2 K753E
|
Breast Cancer
|
trastuzumab Resistant: D – Preclinical
|
trastuzumab Resistant: D – Preclinical
|
HER-2 K753E
|
HER2 Positive Breast Cancer
|
HER-2 K753E
|
HER2 Positive Breast Cancer
|
neratinib Sensitive: D – Preclinical
|
neratinib Sensitive: D – Preclinical
|
HER-2 K753E
|
Breast Cancer
|
HER-2 K753E
|
Breast Cancer
|
lapatinib Resistant: D – Preclinical
|
lapatinib Resistant: D – Preclinical
|